~~<i id='2CE8C07BC9'><strike id='2CE8C07BC9'><tt id='2CE8C07BC9'><pre id='2CE8C07BC9'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-08-18 14:25:34 Page View：295

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 'The View' co
Next article： Sports medicine is finally prioritizing gender equality

explore

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

'The View' co

5:21BillGeddie.HeidiGutman/ABCBillGeddie,thetelevisionproducerwhoco-foundedABC's"TheView&q

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

The biotech scorecard for the 2nd quarter: 12 industry events to watch

APStockIntroducingSTAT’sBiotechQ2Scorecard,ouremoji-enabledmeansoftracking12make-or-breakeventsexpec